Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2003
11/06/2003WO2001078503A3 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/06/2003WO2000033865A8 Methods of inhibiting ectopic calcification
11/06/2003WO2000026247A8 Ikaros isoforms and mutants
11/06/2003US20030208792 A coat protein (CP) or a movement protein (MP) gene is replaced with a nuclear inclusion protease (NIa) expression cassette for the expression of a heterologous peptide in a tobacco ; for purposes of creating a vaccinevaccine
11/06/2003US20030208060 Dyslipidemias, abnormal postprandial triglyceride metabolism or Pattern B phenotype; cellular uptake of plasma chylo-microns; cloning; triglyceride-rich lipoproteins in an ApoE-, lipoprotein lipase- and heparin sulfate proteoglycan pathway
11/06/2003US20030208059 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11/06/2003US20030208058 B7-like polypeptides and polynucleotides
11/06/2003US20030208055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030208054 Fc Receptors and polypeptides
11/06/2003US20030208049 Comprising a molecule bound to Tumor necrosis factor (TNF) and methods of therapy utilising TNF and molecules active against TNF
11/06/2003US20030208048 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use
11/06/2003US20030208047 Relates to ligands which bind to human tumour necrosis factor alpha (TNF) to modify the biological activity
11/06/2003US20030208046 Pseudo native chemical ligation
11/06/2003US20030208045 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM)
11/06/2003US20030208044 Galectin 11
11/06/2003US20030208043 Human genes, sequences and expression products
11/06/2003US20030208042 That show high specificity for nicotinic acetylcholine receptors; are useful in a variety of conditions where localized inhibition of neuronal and/or muscle cell function is desirable
11/06/2003US20030208041 Chloride channel polypeptides and nucleic acids, and their uses in obtaining compounds for preventing or treating a tick infestation
11/06/2003US20030208040 G-protein associated molecules
11/06/2003US20030208039 Use of antibodies encompass procedures for diagnostic and prognostic assay of the polypeptides, as well as methods of treating diverse pathological conditions
11/06/2003US20030208035 Antifungal and/or antibacterial peptides, preparation methods, compositions containing same and methods of treating mammals and/or plants
11/06/2003US20030207944 Aminotetralin derivative for the therapy of cardiovascular diseases
11/06/2003US20030207861 Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
11/06/2003US20030207842 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for
11/06/2003US20030207840 Solid tumors and other conditions related to angiogenesis, including wounds, bone fractures, follicular development, ischemia, retinopathy, psoriasis, and rheumatoid arthritis are treated or detected with reagents which either detect,
11/06/2003US20030207839 Antisense modulation of Jagged 2 expression
11/06/2003US20030207838 Use of pro-apoptotic factors in treatment of atherosclerosis
11/06/2003US20030207835 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
11/06/2003US20030207834 The present invention relates to methods and compositions containing oligonucleotides suitable for administration to humans and other mammals.
11/06/2003US20030207829 methods for treating cancer by administering an effective amount of a modified Herpes simplex virus.
11/06/2003US20030207827 Novel secreted polypeptide, termed osteoprotegerin, which is a member of the tumor necrosis factor receptor superfamily and is involved in the regulation of bone metabolism. Also disclosed are nucleic acids encoding osteoprotegerin,
11/06/2003US20030207816 Inducing or enhancing chondrogenesis in vivo or in vitro. The method is performed by exposing the cells in vitro or in vivo to an extracellular matrix comprising of type I collagen, type II collagen or a mixture of type I collagen or type II
11/06/2003US20030207814 Novel guanidinyl derivatives
11/06/2003US20030207813 Retroviral protease inhibitor combinations
11/06/2003US20030207812 Cd45 inhibitors
11/06/2003US20030207811 Treating or preventing retinopathy of prematurity in a neonatal mammal comprising the step of administering to the mammal, an amount of a somatostatin analog containing composition sufficient to provide a therapeutic benefit.
11/06/2003US20030207809 Glucagon-related peptides and their use for the prevention or treatment of disorders involving the large intestine. In particular, it has now been demonstrated that GLP-2 and peptidic agonists of GLP-2 can cause proliferation of the
11/06/2003US20030207807 A feline hepatocyte growth factor gene and a 15 base pairs-deleted feline hepatocyte growth factor gene. These genes encode the following protein (a) or (b): a protein having an amino acid sequence shown in SEQ ID NO: 2 or 4; and a protein
11/06/2003US20030207802 Polypeptide compositions with improved stability
11/06/2003US20030207801 Novel polypeptides and nucleic acids encoding same
11/06/2003US20030207799 Purification of DNA encoding a numerous polypeptides useful for the stimulation of glial cell (particularly, Schwann cell) mitogenesis and treating glial cell tumors. Also disclosed are DNA sequences encoding novel polypeptide which
11/06/2003US20030207798 Hair growth promoting agent including a cyclosporin derivative as an active ingredient, and more particularly, a hair growth promoting agent including a cyclosporin A derivative substituted in the 3-position as an active ingredient.
11/06/2003US20030207797 Glycopeptides that are substituted with one or more substituents each comprising one or more phosphono groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful
11/06/2003US20030207796 Specifically bind a carbohydrate target wherein sialic acid is linked at the nonreducing terminus of a glycoside to a galactose or galactosamine residue through an alpha 2-6 linkage are able to inhibit the conversion of human Factor X
11/06/2003US20030207795 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
11/06/2003US20030207451 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
11/06/2003US20030207447 Used to distinguish between arterial endothelial cells (arteries) and venous endothelial cells (veins)
11/06/2003US20030207446 Infectious papillomavirus pseudoviral particles
11/06/2003US20030207435 Have increased anti-coagulation activity and resistance to inactivation by serpins
11/06/2003US20030207434 Phosphodiesterases
11/06/2003US20030207429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207427 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207426 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207425 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207424 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207423 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207422 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207421 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207420 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207419 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207418 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207417 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207416 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207415 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207414 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207404 Detection reagents for TPC2 and TPC3, two proteins that are coexpressed with telomerase
11/06/2003US20030207403 For diagnosis or treatment of diseases with beta 10 polypeptides and alpha 2/ beta 10 heterodimers or their respective binding agents, such as thyroid gland disorders
11/06/2003US20030207401 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207391 Used to prevent dimerisation of vascular endothelial growth factor (VEGF)
11/06/2003US20030207390 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207389 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207388 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207387 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207386 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207385 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207384 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207383 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207382 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207381 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207379 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207378 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207377 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207376 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207374 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207373 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207372 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207371 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207370 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207369 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207368 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207366 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207365 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207364 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207363 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207361 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207360 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207359 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
1 ... 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 ... 3163